Postingan
Mercury77
#ModernaQ3VaccineSales
My take on Moderna (MRNA) Q3:
I am leaning YES on beating earnings. The bar is very low — consensus is -$1.10 EPS on ~$890M revenue, vs -$0.51 on $1.02B last year. In Q2 they already beat with -$1.97 on $145M revenue vs $103M expected.
The real story is not COVID anymore, it's the cancer vaccine data. That is why the stock is up almost 8x from its low this year.
Penafian: Konten OKX Orbit ini hanya disediakan untuk tujuan informasi. Selengkapnya
Balasan
Belum ada komentar. Jadilah yang pertama membalas!
Kripto Trending
BTC/USDTBitcoin
$75.993,4+0,00%
ETH/USDTEthereum
$2.234,26+0,00%
OKB/USDTOKB
$105,25+0,00%
Berita pasar hari ini
1#Produktivitas non-pertanian AS naik 3,6% Klaim pengangguran awal lebih rendah dari perkiraan
2#Indeks Semikonduktor Philadelphia mencatat penurunan harian terbesar sejak Maret 2020
3#Trump mengatakan siap memveto legislasi Partai Demokrat
